Fair Pricing Forum 2021: Promoting transparency for accountable medical innovation

Update: You can read the meeting report from the Fair Pricing Forum 2021 here.

The 2021 Fair Pricing Forum seeks to:

•  Share countries’ experiences in ensuring affordability and transparency of prices and costs of health products, including medicines

• Advance discussion and knowledge of approaches and system factors pertaining to the pricing and R&D of pharmaceutical products for enhancing affordability, transparency, and innovation, and achieving health sustainable development goals

• Increase support for countries to achieve more affordable and fairer access to pharmaceutical products during the COVID-19 pandemic and beyond. 

This year's forum will additionally include the opportunity for countries to share their experiences with the COVID-19 pandemic.

Sharing findings from the 2021 Access to Medicine Index
Claudia Martínez will deliver introductory remarks for Parallel Session 2, 'Promoting transparency for accountable medical innovation’, and join an expert panel to discuss the role of transparency in ensuring accountability for incentives to achieve fair prices and spur access to products. In her introduction, Claudia will discuss: 

• The Access to Medicine Index as a tool to monitor and drive change in pharmaceutical companies’ actions in access to medicine;

• Trends in the implementation of equitable access strategies by pharmaceutical companies, key findings from 2021 the Access to Medicine Index and the need for change at scale.

Other speakers at the event will include:

• Lenias Hwenda, Medicines for Africa

• Anne Hendrickx, Union Nationale des Mutualités Socialistes – Solidaris

• Isao Kamae, University of Tokyo

• Pauline Londeix, Observatoire Transparence Médicaments

• Corey Salsberg, Novartis and IPFMA

The discussion will be moderated by Sabine Vogler of the Austrian Public Health Institute.

More details about the 2021 Fair Pricing Forum can be found here.